GeoVax Labs, Inc.
GOVX
$0.72
$0.000.03%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -100.00% | -- | 183.44% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -100.00% | -- | 183.44% |
| Cost of Revenue | -34.22% | -27.10% | -60.64% | -31.87% | 10.57% |
| Gross Profit | 19.76% | -5.00% | 55.60% | -9.32% | 2.50% |
| SG&A Expenses | -13.66% | -18.85% | -9.58% | 7.13% | 42.01% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -29.17% | -25.12% | -51.77% | -26.27% | 16.94% |
| Operating Income | 18.03% | 2.45% | 46.77% | -8.86% | -7.05% |
| Income Before Tax | 17.56% | 1.79% | 46.53% | -8.66% | -6.04% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | 17.56% | 1.79% | 46.53% | -8.66% | -6.04% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 17.56% | 1.79% | 46.53% | -8.66% | -6.04% |
| EBIT | 18.03% | 2.45% | 46.77% | -8.86% | -7.05% |
| EBITDA | 17.99% | 2.36% | 46.85% | -9.14% | -7.22% |
| EPS Basic | 88.91% | 76.61% | 88.11% | 65.70% | 82.47% |
| Normalized Basic EPS | 88.91% | 76.61% | 88.11% | 65.70% | 82.47% |
| EPS Diluted | 88.91% | 76.61% | 88.11% | 65.70% | 82.47% |
| Normalized Diluted EPS | 88.91% | 76.61% | 88.11% | 65.70% | 82.47% |
| Average Basic Shares Outstanding | 643.03% | 319.93% | 349.56% | 216.74% | 504.72% |
| Average Diluted Shares Outstanding | 643.03% | 319.93% | 349.56% | 216.74% | 504.72% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |